Determination of tissue concentrations of metabolites in surgical preparations following inhalation of beclomethasone-dipropionate using conventional and extrafine aerosols
O. Holz, M. Einhaus, I. Zühlke, D. Branscheid, M. Nakashima, L. Welker, F. Kanniess, K. Richter, S. Hader, L. Harrison, R. A. Jörres, H. Magnussen (Grosshansdorf, Neuss, Germany; St Paul, United States Of America)
Source: Annual Congress 2003 - Issues surrounding drug delivery
Session: Issues surrounding drug delivery
Session type: Thematic Poster Session
Number: 2980
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Holz, M. Einhaus, I. Zühlke, D. Branscheid, M. Nakashima, L. Welker, F. Kanniess, K. Richter, S. Hader, L. Harrison, R. A. Jörres, H. Magnussen (Grosshansdorf, Neuss, Germany; St Paul, United States Of America). Determination of tissue concentrations of metabolites in surgical preparations following inhalation of beclomethasone-dipropionate using conventional and extrafine aerosols. Eur Respir J 2003; 22: Suppl. 45, 2980
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Aerosol performance of two ambroxol inhalation products upon nebulisation by the eFlow rapid Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006
A novel tool for the assessment of pulmonary disposition of dry powder aerosols; the isolated and perfused rat lung exposed to budesonide, formoterol and terbutaline Source: Eur Respir J 2007; 30: Suppl. 51, 352s Year: 2007
Plasma concentrations of four corticosteroids following inhalation Source: Eur Respir J 2005; 26: Suppl. 49, 215s Year: 2005
Urinary pharmacokinetic method to identify the relative bioavailability of beclometasone dipropionate (BDP) to the lung and body following inhalation Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010
Effect of device and formulation on delivery of budesonide suspensions by nebulizers Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
Greater esterification and retention of budesonide in the airways and lung as compared to ciclesonide after repeated intratracheal administration in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004
Hydrofluoroalkane beclomethasone dipropionate extra fine aerosol efficacy response at reduced dose compared to other inhaled corticosteroid treatment regimens Source: Eur Respir J 2001; 18: Suppl. 33, 70s Year: 2001
Do dry powder inhalers (DPIs) have a ‘Goldilocks Zone’ of inhalation? In vitro lung deposition of Budesonide/Formoterol (BUD/FORM) DPI with different inhalation profiles Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017
Comparison of systemic bioavailability of two formulations of budesonide nebulized suspension in healthy subjects Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Concentrations of ciclesonide and its metabolites in the human lung after inhalation of 1280 μg ciclesonide Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006
Estimation of efficiency of new combined preparation built-in-liposomes budesonide compared with water budesonide suspension Source: Eur Respir J 2004; 24: Suppl. 48, 83s Year: 2004
The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005
Ex-vivo emitted dose characteristics for combination formulations in dry powder inhalers (DPI) Source: Eur Respir J 2003; 22: Suppl. 45, 472s Year: 2003
Comparison of the release characteristics of formoterol dihydrate powder for inhalation delivered through two different types of multidose dry powder inhalers (MDPI) Source: Eur Respir J 2005; 26: Suppl. 49, 126s Year: 2005
Efficient deposition and absorption of orally inhaled indacaterol in the lungs Source: Annual Congress 2011 - COPD management Year: 2011
Pharmacokinetics and pharmacodynamics of beclomethasone dipropionate and formoterol combination after inhalation using a new dry powder inhaler Source: Eur Respir J 2007; 30: Suppl. 51, 350s Year: 2007
Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006
Efficient deposition and sustained lung concentrations of NVA237 after inhalation via the Breezhaler® device in man Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012
Side effects of inhaled budesonide through different types of inhalers Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
Different inhalation volumes do not impact on the aerodynamics of aclidinium bromide delivered using the Genuair® inhaler Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010